Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes

NCT06570278 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT06570278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06570278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Not applicable
Overall status
Recruiting
Start date
October 30, 2024
Completion date
November 30, 2034
Enrollment
1,020 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus